Figure 1.

Various concentrations (10–160 µM) and durations (1–5 days) of apigenin treatment resulted in a dose- and time-dependent inhibition of ACC-2 human adenoid cystic carcinoma cell growth, as determined by Cell Counting kit-8. ^*P<0.05 vs. control on days 2–5.